My NCBISign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 100

    1.

    Mucins in ovarian cancer diagnosis and therapy.

    Chauhan SC, Kumar D, Jaggi M.

    J Ovarian Res. 2009 Dec 24;2:21.PMID: 20034397 [PubMed - in process]Free PMC ArticleFree textRelated citations

    2.

    Clinical potential of mucins in diagnosis, prognosis, and therapy of ovarian cancer.

    Singh AP, Senapati S, Ponnusamy MP, Jain M, Lele SM, Davis JS, Remmenga S, Batra SK.

    Lancet Oncol. 2008 Nov;9(11):1076-85. Review.PMID: 19012856 [PubMed - indexed for MEDLINE]Related citations

    3.

    Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.

    Piver MS.

    Oncologist. 1996;1(5):326-330.PMID: 10388011 [PubMed - as supplied by publisher]Free ArticleRelated citations

    4.

    Overview of resistance to systemic therapy in patients with breast cancer.

    Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN.

    Adv Exp Med Biol. 2007;608:1-22. Review.PMID: 17993229 [PubMed - indexed for MEDLINE]Related citations

    5.

    Mucin gene expression in ovarian cancers.

    Giuntoli RL 2nd, Rodriguez GC, Whitaker RS, Dodge R, Voynow JA.

    Cancer Res. 1998 Dec 1;58(23):5546-50.PMID: 9850092 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

    6.

    "Just Another Statistic"

    Machtay M, Glatstein E.

    Oncologist. 1998;3(3):III-IV.PMID: 10388105 [PubMed - as supplied by publisher]Free ArticleRelated citations

    7.

    Prospective on ovarian cancer: why prevent?

    Hoskins WJ.

    J Cell Biochem Suppl. 1995;23:189-99. Review.PMID: 8747396 [PubMed - indexed for MEDLINE]Related citations

    8.

    Circulating mucins as tumor markers in ovarian cancer (review).

    Devine PL, McGuckin MA, Ward BG.

    Anticancer Res. 1992 May-Jun;12(3):709-17. Review.PMID: 1622128 [PubMed - indexed for MEDLINE]Related citations

    9.

    [Elevated expression of matrix metalloproteinase-9, and fibronectin concentration in recurrent epithelial ovarian cancer]

    Demeter A, Szirmai K, Oláh J, Papp Z, Jeney A.

    Orv Hetil. 2004 Aug 1;145(31):1617-24. Hungarian. PMID: 15384859 [PubMed - indexed for MEDLINE]Related citations

    10.

    Prevention and early detection of ovarian cancer: mission impossible?

    Bast RC Jr, Brewer M, Zou C, Hernandez MA, Daley M, Ozols R, Lu K, Lu Z, Badgwell D, Mills GB, Skates S, Zhang Z, Chan D, Lokshin A, Yu Y.

    Recent Results Cancer Res. 2007;174:91-100. Review.PMID: 17302189 [PubMed - indexed for MEDLINE]Related citations

    11.

    Aberrant expression of MUC4 in ovarian carcinoma: diagnostic significance alone and in combination with MUC1 and MUC16 (CA125).

    Chauhan SC, Singh AP, Ruiz F, Johansson SL, Jain M, Smith LM, Moniaux N, Batra SK.

    Mod Pathol. 2006 Oct;19(10):1386-94. Epub 2006 Jul 28.PMID: 16880776 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

    12.

    Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer.

    Welsh JB, Zarrinkar PP, Sapinoso LM, Kern SG, Behling CA, Monk BJ, Lockhart DJ, Burger RA, Hampton GM.

    Proc Natl Acad Sci U S A. 2001 Jan 30;98(3):1176-81.PMID: 11158614 [PubMed - indexed for MEDLINE]Free PMC ArticleFree textRelated citations

    13.

    Epithelial ovarian cancer: disease etiology, treatment, detection, and investigational gene, metabolite, and protein biomarkers.

    Williams TI, Toups KL, Saggese DA, Kalli KR, Cliby WA, Muddiman DC.

    J Proteome Res. 2007 Aug;6(8):2936-62. Epub 2007 Jun 21. Review.PMID: 17583933 [PubMed - indexed for MEDLINE]Related citations

    14.

    Current status of mucins in the diagnosis and therapy of cancer.

    Rachagani S, Torres MP, Moniaux N, Batra SK.

    Biofactors. 2009 Nov-Dec;35(6):509-27. Review.PMID: 19904814 [PubMed - indexed for MEDLINE]Free PMC ArticleFree textRelated citations

    15.

    Retinoids and ovarian cancer.

    Zhang D, Holmes WF, Wu S, Soprano DR, Soprano KJ.

    J Cell Physiol. 2000 Oct;185(1):1-20. Review.PMID: 10942515 [PubMed - indexed for MEDLINE]Related citations

    16.

    High insulin-like growth factor-2 (IGF-2) gene expression is an independent predictor of poor survival for patients with advanced stage serous epithelial ovarian cancer.

    Sayer RA, Lancaster JM, Pittman J, Gray J, Whitaker R, Marks JR, Berchuck A.

    Gynecol Oncol. 2005 Feb;96(2):355-61.PMID: 15661221 [PubMed - indexed for MEDLINE]Related citations

    17.

    Pathogenesis of ovarian cancer: lessons from morphology and molecular biology and their clinical implications.

    Kurman RJ, Shih IeM.

    Int J Gynecol Pathol. 2008 Apr;27(2):151-60. Review.PMID: 18317228 [PubMed - indexed for MEDLINE]Free PMC ArticleFree textRelated citations

    18.

    Klotho expression in epithelial ovarian cancer and its association with insulin-like growth factors and disease progression.

    Lu L, Katsaros D, Wiley A, de la Longrais IA, Puopolo M, Yu H.

    Cancer Invest. 2008 Mar;26(2):185-92.PMID: 18259951 [PubMed - indexed for MEDLINE]Related citations

    19.

    Interleukin-13 receptor alpha2 chain: a potential biomarker and molecular target for ovarian cancer therapy.

    Kioi M, Kawakami M, Shimamura T, Husain SR, Puri RK.

    Cancer. 2006 Sep 15;107(6):1407-18.PMID: 16902988 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

    20.

    Gynecological malignancies.

    Schaebler DL, Schilder RJ, Young RC.

    Cancer Chemother Biol Response Modif. 1996;16:564-91. Review.PMID: 8639401 [PubMed - indexed for MEDLINE]Related citations

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity

    You are here: NCBI > Literature > PubMed
    Write to the Help Desk